Literature DB >> 26805391

Non-sustained ventricular tachycardia in patients with congenital heart disease: An important sign?

Christophe P Teuwen1, Tanwier T T K Ramdjan1, Marco Götte2, Bianca J J M Brundel3, Reinder Evertz4, Joris W J Vriend2, Sander G Molhoek5, H G Reinhart Dorman6, Jurren M van Opstal6, Thelma C Konings7, Pepijn van der Voort8, Etienne Delacretaz9, Nienke J Wolfhagen1, Virgilla van Gastel1, Peter de Klerk1, Dominic A Theuns1, Maarten Witsenburg1, Jolien W Roos-Hesselink1, John K Triedman10, Ad J J C Bogers11, Natasja M S de Groot12.   

Abstract

BACKGROUND: Sustained ventricular tachycardia (susVT) and ventricular fibrillation (VF) are observed in adult patients with congenital heart disease (CHD). These dysrhythmias may be preceded by non-sustained ventricular tachycardia (NSVT). The aims of this study are to examine the 1] time course of ventricular tachyarrhythmia (VTA) in a large cohort of patients with various CHDs and 2] the development of susVT/VF after NSVT.
METHODS: In this retrospective study, patients with VTA on ECG, 24-hour Holter or ICD-printout or an out-of-hospital-cardiac arrest due to VF were included. In patients with an ICD, the number of shocks was studied.
RESULTS: Patients (N=145 patients, 59% male) initially presented with NSVT (N=103), susVT (N=25) or VF (N=17) at a mean age of 40 ± 14 years. Prior to VTA, 58 patients had intraventricular conduction delay, 14 an impaired ventricular dysfunction and 3 had coronary artery disease. susVT/VF rarely occurred in patients with NSVT (N=5). Fifty-two (36%) patients received an ICD; appropriate and inappropriate shocks, mainly due to supraventricular tachycardia (SVT), occurred in respectively 15 (29%) (NSVT: N=1, susVT: N=9, VF: N=5) and 12 (23%) (NSVT: N=4, susVT: N=5, VF: N=3) patients.
CONCLUSIONS: VTA in patients with CHD appear on average at the age of 40 years. susVT/VF rarely developed in patients with only NSVT, whereas recurrent episodes of susVT/VF frequently developed in patients initially presenting with susVT/VF. Hence, a wait-and-see treatment strategy in patients with NSVT and aggressive therapy of both episodes of VTA and SVT in patients with susVT/VF seems justified.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Congenital heart defects; Implantable cardioverter defibrillator; Ventricular tachyarrhythmia

Mesh:

Year:  2016        PMID: 26805391     DOI: 10.1016/j.ijcard.2016.01.042

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  2 in total

1.  Hidden burden of arrhythmias in patients with small atrial septal defects: a nationwide study.

Authors:  Sebastian Udholm; Camilla Nyboe; Andrew Redington; Jens Erik Nielsen-Kudsk; Jens Cosedis Nielsen; Vibeke Elisabeth Hjortdal
Journal:  Open Heart       Date:  2019-06-29

2.  Hemodialysis Procedure-Associated Autonomic Imbalance and Cardiac Arrhythmias: Insights From Continuous 14-Day ECG Monitoring.

Authors:  Nichole M Rogovoy; Stacey J Howell; Tiffany L Lee; Christopher Hamilton; Erick A Perez-Alday; Muammar M Kabir; Yanwei Zhang; Esther D Kim; Jessica Fitzpatrick; Jose M Monroy-Trujillo; Michelle M Estrella; Stephen M Sozio; Bernard G Jaar; Rulan S Parekh; Larisa G Tereshchenko
Journal:  J Am Heart Assoc       Date:  2019-09-28       Impact factor: 5.501

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.